NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 1.630
+0.020 (1.24%)
At close: Aug 26, 2026
NovaBridge Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 190.64 | 210.63 | 68.26 | 291.51 | 465.99 | 554.68 |
Short-Term Investments | 0.21 | 0.21 | 105.14 | 20.22 | 34.8 | 118.56 |
Cash & Short-Term Investments | 190.85 | 210.84 | 173.4 | 311.73 | 500.78 | 673.24 |
Cash Growth | 15.24% | 21.59% | -44.38% | -37.75% | -25.61% | -8.25% |
Accounts Receivable | - | - | - | - | - | 45.16 |
Other Receivables | 5.64 | 1.79 | 1.17 | 1.83 | 4.81 | 16 |
Receivables | 5.64 | 1.79 | 1.17 | 1.83 | 4.81 | 61.16 |
Inventory | - | - | - | - | - | 4.29 |
Prepaid Expenses | 1.12 | 0.7 | 1.13 | 0.12 | 1.38 | 1.41 |
Restricted Cash | - | - | - | - | 14.03 | - |
Other Current Assets | 0.39 | 4.19 | 1 | 16.23 | 4.78 | 12.62 |
Total Current Assets | 198 | 217.52 | 176.69 | 329.91 | 525.79 | 752.72 |
Property, Plant & Equipment | 5.61 | 2.95 | 3.8 | 5.55 | 17.97 | 24.95 |
Long-Term Investments | 25.06 | 37.24 | 30.82 | - | 4.47 | 55.43 |
Goodwill | - | - | - | - | 23.57 | 25.59 |
Other Intangible Assets | - | - | - | - | 17.24 | 18.84 |
Other Long-Term Assets | 2.87 | 2.81 | 1.37 | 33.46 | 1.58 | 4.19 |
Total Assets | 231.54 | 260.52 | 212.68 | 368.92 | 590.63 | 881.72 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accrued Expenses | 11.13 | 16.82 | 7.53 | 6.58 | 100.48 | 92.27 |
Short-Term Debt | - | - | - | - | 2.75 | - |
Current Portion of Leases | 1.28 | 0.89 | 0.82 | 0.63 | 3.47 | 4.83 |
Current Unearned Revenue | - | - | - | - | 1.26 | - |
Other Current Liabilities | 8.88 | 9.18 | 0.11 | 50.94 | 1.96 | 1.13 |
Total Current Liabilities | 25.92 | 26.89 | 8.45 | 58.14 | 109.92 | 98.23 |
Long-Term Leases | 3.18 | 2.18 | 3.07 | 3.26 | 4.65 | 12.87 |
Long-Term Unearned Revenue | - | - | - | - | 38.84 | 35.26 |
Other Long-Term Liabilities | 1.33 | 0.51 | - | 64.93 | 15.32 | 17.61 |
Total Liabilities | 30.44 | 29.58 | 11.52 | 126.34 | 168.73 | 163.97 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
Additional Paid-In Capital | 1,533 | 1,527 | 1,460 | 1,475 | 1,389 | 1,433 |
Retained Earnings | -1,370 | -1,332 | -1,286 | -1,264 | -994.92 | -685.52 |
Treasury Stock | -3.71 | -5.04 | -6.23 | -8.01 | -3.08 | - |
Comprehensive Income & Other | 42.04 | 41.55 | 33.38 | 39.77 | 31 | -29.36 |
Total Common Equity | 201.1 | 230.94 | 201.16 | 242.58 | 421.9 | 717.75 |
Shareholders' Equity | 201.1 | 230.94 | 201.16 | 242.58 | 421.9 | 717.75 |
Total Liabilities & Equity | 231.54 | 260.52 | 212.68 | 368.92 | 590.63 | 881.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.46 | 3.07 | 3.88 | 3.89 | 10.87 | 17.7 |
Net Cash (Debt) | 186.39 | 207.78 | 169.52 | 307.84 | 489.91 | 655.53 |
Net Cash Growth | 14.96% | 22.57% | -44.93% | -37.16% | -25.26% | -10.41% |
Net Cash Per Share | 1.65 | 2.17 | 2.09 | 3.70 | 5.94 | 8.63 |
Filing Date Shares Outstanding | 116 | 115.65 | 81.5 | 80.7 | 82.99 | 82.55 |
Total Common Shares Outstanding | 116 | 115.38 | 81.5 | 80.7 | 82.99 | 79.92 |
Working Capital | 172.08 | 190.63 | 168.24 | 271.77 | 415.87 | 654.49 |
Book Value Per Share | 1.73 | 2.00 | 2.47 | 3.01 | 5.08 | 8.98 |
Tangible Book Value | 201.1 | 230.94 | 201.16 | 242.58 | 381.09 | 673.32 |
Tangible Book Value Per Share | 1.73 | 2.00 | 2.47 | 3.01 | 4.59 | 8.42 |
Machinery | - | - | - | 1.77 | 9.33 | 6.1 |
Construction In Progress | - | - | - | - | 0.9 | 3.32 |
Leasehold Improvements | - | - | - | 0.87 | 5.42 | 2.98 |